SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 05/07/2019
Entire Document
 

 

In re: Pernix Sleep, Inc. et al. Case No. 19-10323 (CSS)
Debtors Reporting Period: February 18, 2019 - March 31, 2019

 

MOR-5
Accounts Receivable Aging
As of March 31, 2019
(Unaudited)

 

$ USD '000s 

                  
   Number of Days Past Due
Accounts Receivable Aging  Current  0-30 Days  31-60 Days  61-90 Days  91 Days+  Total
Accounts Receivable, net  $21,206   $11,953   $1,595   $1,475   $257   $36,486 
  $21,206   $11,953   $1,595   $1,475   $257   $36,486 

 

Debtor Questionnaire

 

Must be completed each month Yes No

1.

 

Have any assets been sold or transferred outside the normal course of business
this reporting period?  If yes, provide an explanation below.
X  

2.

 

Have any funds been disbursed from any account other than a debtor in possession
account this reporting period?  If yes, provide an explanation below.
  X

3.

 

Have all post petition tax returns been timely filed? If no, provide an explanation
below.
X  

4.

 

Are workers compensation, general liability and other necessary insurance
coverages in effect?  If no, provide an explanation below.
X  

5.

 

Has any bank account been opened during the reporting period? If yes, provide
documentation identifying the opened account(s). If an investment account has been
opened provide the required documentation pursuant to the Delaware Local Rule 4001-3. 

X  

 

Notes: 

1) The Debtors sold office furniture and fixtures in connection with ending the South Carolina office space lease.
5) Wells Fargo account 0526 was opened during this period as an escrow account to hold Nalpropion operating receipts.

 

12